March 05, 2021 Boston Scientific’s next move The cardiovascular specialist needs to buy its way to growth – and it has marked an interest in a handful of smaller companies.
March 04, 2021 March medtech merger madness High asset prices and a need to release the pandemic’s brake on growth force medtechs to splash the cash.
